Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Begins Shipping New BioXL Analysis Computer

Premium

PETACH-TIKVA, Israel--Compugen here has begun shipping BioXL, its newest high-end sequence analysis computer system designed for target discovery. The scalable system includes proprietary components on both the hardware and the software side. "With BioXL's superior functionality, algorithmic range, and computational power that scales to more than 50-gig matrix cell updates per second, our clients can now enjoy the ultimate solution for sequence data mining," claimed Meir Yedidia, Compugen's marketing manager of sequence analysis products.

Compugen develops proprietary bioinformatics technologies and markets them to pharmaceutical and genomics companies for use in analyzing genomic and protein sequence data and discovering of new drug leads. The company has satellite offices in Woburn, Mass., and Japan.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.